Sign in
|
Register
Home
Browse
Submit data
About SASBDB
Help
Search
Advanced search
14
hits found for
Martin Schroer
SASDMY3
– Lysozyme amyloid fibril (LAF)
Sample:
lysozyme amyloid fibril , 1 kDa
Gallus gallus
protein
Buffer:
0.2 M glycine-HCl, 80 mM NaCl, pH: 2.2
Experiment:
SAXS data collected at EMBL P12, PETRA III
on 2018 Nov 29
Dependence of the Nanoscale Composite Morphology of Fe3O4 Nanoparticle-Infused Lysozyme Amyloid Fibrils on Timing of Infusion: A Combined SAXS and AFM Study
Molecules
26(16):4864 (2021)
Schroer
M, Hu P, Tomasovicova N, Batkova M, Zakutanska K, Wu P, Kopcansky P
R
g
Guinier
38.4
nm
D
max
80.0
nm
SASDMZ3
– Fe3O4 nanoparticles (10 nm diameter)
Sample:
Fe3O4 nanoparticles; nominal diameter 10 nm (hydrodynamic diameter) monomer, 1 kDa
Buffer:
50 mM borate buffer, 0.02% NaN3, pH: 8.5
Experiment:
SAXS data collected at EMBL P12, PETRA III
on 2018 Nov 29
Dependence of the Nanoscale Composite Morphology of Fe3O4 Nanoparticle-Infused Lysozyme Amyloid Fibrils on Timing of Infusion: A Combined SAXS and AFM Study
Molecules
26(16):4864 (2021)
Schroer
M, Hu P, Tomasovicova N, Batkova M, Zakutanska K, Wu P, Kopcansky P
R
g
Guinier
7.0
nm
D
max
8.0
nm
SASDM24
– Fe3O4 nanoparticles (20 nm diameter)
Sample:
Fe3O4 nanoparticles; nominal diameter 20 nm (hydrodynamic diameter) monomer, 1 kDa
Buffer:
50 mM borate buffer, 0.02% NaN3, pH: 8.5
Experiment:
SAXS data collected at EMBL P12, PETRA III
on 2018 Nov 29
Dependence of the Nanoscale Composite Morphology of Fe3O4 Nanoparticle-Infused Lysozyme Amyloid Fibrils on Timing of Infusion: A Combined SAXS and AFM Study
Molecules
26(16):4864 (2021)
Schroer
M, Hu P, Tomasovicova N, Batkova M, Zakutanska K, Wu P, Kopcansky P
R
g
Guinier
11.0
nm
D
max
14.0
nm
SASDM34
– Fe3O4 nanoparticles (30 nm diameter)
Sample:
Fe3O4 nanoparticles; nominal diameter 30 nm (hydrodynamic diameter) monomer, 1 kDa
Buffer:
50 mM borate buffer, 0.02% NaN3, pH: 8.5
Experiment:
SAXS data collected at EMBL P12, PETRA III
on 2018 Nov 29
Dependence of the Nanoscale Composite Morphology of Fe3O4 Nanoparticle-Infused Lysozyme Amyloid Fibrils on Timing of Infusion: A Combined SAXS and AFM Study
Molecules
26(16):4864 (2021)
Schroer
M, Hu P, Tomasovicova N, Batkova M, Zakutanska K, Wu P, Kopcansky P
R
g
Guinier
18.1
nm
D
max
16.9
nm
SASDM44
– LAF + P10 nanocomposite (NP added before fibrilization)
Sample:
lysozyme amyloid fibril , 1 kDa
Gallus gallus
protein
Fe3O4 nanoparticles; nominal diameter 10 nm (hydrodynamic diameter) monomer, 1 kDa
Buffer:
0.2 M glycine-HCl, 80 mM NaCl, pH: 2.2
Experiment:
SAXS data collected at EMBL P12, PETRA III
on 2018 Nov 29
Dependence of the Nanoscale Composite Morphology of Fe3O4 Nanoparticle-Infused Lysozyme Amyloid Fibrils on Timing of Infusion: A Combined SAXS and AFM Study
Molecules
26(16):4864 (2021)
Schroer
M, Hu P, Tomasovicova N, Batkova M, Zakutanska K, Wu P, Kopcansky P
R
g
Guinier
22.3
nm
D
max
70.0
nm
SASDM54
– LAF + P30 nanocomposite (NP added before fibrilization)
Sample:
lysozyme amyloid fibril , 1 kDa
Gallus gallus
protein
Fe3O4 nanoparticles; nominal diameter 30 nm (hydrodynamic diameter) monomer, 1 kDa
Buffer:
0.2 M glycine-HCl, 80 mM NaCl, pH: 2.2
Experiment:
SAXS data collected at EMBL P12, PETRA III
on 2018 Nov 29
Dependence of the Nanoscale Composite Morphology of Fe3O4 Nanoparticle-Infused Lysozyme Amyloid Fibrils on Timing of Infusion: A Combined SAXS and AFM Study
Molecules
26(16):4864 (2021)
Schroer
M, Hu P, Tomasovicova N, Batkova M, Zakutanska K, Wu P, Kopcansky P
R
g
Guinier
22.5
nm
D
max
95.0
nm
SASDM64
– LAF + P20 nanocomposite (NP added before fibrilization)
Sample:
lysozyme amyloid fibril , 1 kDa
Gallus gallus
protein
Fe3O4 nanoparticles; nominal diameter 20 nm (hydrodynamic diameter) monomer, 1 kDa
Buffer:
0.2 M glycine-HCl, 80 mM NaCl, pH: 2.2
Experiment:
SAXS data collected at EMBL P12, PETRA III
on 2018 Nov 29
Dependence of the Nanoscale Composite Morphology of Fe3O4 Nanoparticle-Infused Lysozyme Amyloid Fibrils on Timing of Infusion: A Combined SAXS and AFM Study
Molecules
26(16):4864 (2021)
Schroer
M, Hu P, Tomasovicova N, Batkova M, Zakutanska K, Wu P, Kopcansky P
R
g
Guinier
23.6
nm
D
max
90.0
nm
SASDM74
– LAF + P20 nanocomposite (NP added after fibrilization)
Sample:
lysozyme amyloid fibril , 1 kDa
Gallus gallus
protein
Fe3O4 nanoparticles; nominal diameter 20 nm (hydrodynamic diameter) monomer, 1 kDa
Buffer:
0.2 M glycine-HCl, 80 mM NaCl, pH: 2.2
Experiment:
SAXS data collected at EMBL P12, PETRA III
on 2018 Sep 2
Dependence of the Nanoscale Composite Morphology of Fe3O4 Nanoparticle-Infused Lysozyme Amyloid Fibrils on Timing of Infusion: A Combined SAXS and AFM Study
Molecules
26(16):4864 (2021)
Schroer
M, Hu P, Tomasovicova N, Batkova M, Zakutanska K, Wu P, Kopcansky P
R
g
Guinier
31.0
nm
D
max
75.0
nm
SASDMJ4
– Lysozyme amyloid fibril (LAF)
Sample:
lysozyme amyloid fibril , 14 kDa
Gallus gallus
protein
Buffer:
0.2 M glycine-HCl, 80 mM NaCl, pH: 2.2
Experiment:
SAXS data collected at EMBL P12, PETRA III
on 2016 Sep 5
Effect of the concentration of protein and nanoparticles on the structure of biohybrid nanocomposites.
Biopolymers
111(2):e23342 (2020)
...
Schroer
MA, Tomašovičová N, Batková M, Hu PS, Kubovčíková M, Svergun DI, Kopčanský P
R
g
Guinier
30.2
nm
D
max
120.0
nm
SASDMK4
– Fe3O4 nanoparticles (radius 5.6 nm )
Sample:
Fe3O4 nanoparticles; radius 5.6 nm (AFM based) monomer, 1 kDa
Buffer:
water, HCLO4, pH: 7
Experiment:
SAXS data collected at EMBL P12, PETRA III
on 2016 Sep 5
Effect of the concentration of protein and nanoparticles on the structure of biohybrid nanocomposites.
Biopolymers
111(2):e23342 (2020)
...
Schroer
MA, Tomašovičová N, Batková M, Hu PS, Kubovčíková M, Svergun DI, Kopčanský P
R
g
Guinier
11.0
nm
D
max
20.0
nm
SASDML4
– LAF + MNP (r = 5.6 nm) nanocomposite
Sample:
lysozyme amyloid fibril , 1 kDa
Gallus gallus
protein
Fe3O4 nanoparticles; radius 5.6 nm (AFM based) monomer, 1 kDa
Buffer:
0.2 M glycine-HCl, 80 mM NaCl, pH: 2.2
Experiment:
SAXS data collected at EMBL P12, PETRA III
on 2016 Sep 8
Effect of the concentration of protein and nanoparticles on the structure of biohybrid nanocomposites.
Biopolymers
111(2):e23342 (2020)
...
Schroer
MA, Tomašovičová N, Batková M, Hu PS, Kubovčíková M, Svergun DI, Kopčanský P
R
g
Guinier
29.4
nm
D
max
80.0
nm
SASDRK9
– single self-amplifying RNA
Sample:
self-amplifying RNA monomer, 3030 kDa RNA
Buffer:
MBG buffer: 5% w/v D-Glucose, 10mM MES (2-(N-morpholino)ethanesulfonic acid) in double distillated sterile/RNAse free water, pH: 6.1
Experiment:
SAXS data collected at EMBL P12, PETRA III
on 2019 Nov 10
Compact polyethylenimine-complexed mRNA molecules as quintessential vaccines
Martin
Schroer
R
g
Guinier
90.5
nm
D
max
200.0
nm
SASDRL9
– single self-amplifying RNA + 50 mM NaCl
Sample:
self-amplifying RNA monomer, 3030 kDa RNA
Buffer:
MBG buffer: 5% w/v D-Glucose, 10mM MES (2-(N-morpholino)ethanesulfonic acid) in double distillated sterile/RNAse free water, pH: 6.1
Experiment:
SAXS data collected at EMBL P12, PETRA III
on 2020 Mar 10
Compact polyethylenimine-complexed mRNA molecules as quintessential vaccines
Martin
Schroer
R
g
Guinier
30.7
nm
D
max
107.4
nm
Volume
Porod
112000
nm
3
SASDRM9
– Polyethylenimine-compacted single self-amplifying RNA for prophylactic and therapeutic application, specifically for vaccination
Sample:
self-amplifying RNA monomer, 3030 kDa RNA
linear polyethylenimine monomer, 25 kDa
none (polymer)
Buffer:
MBG buffer: 5% w/v D-Glucose, 10mM MES (2-(N-morpholino)ethanesulfonic acid) in double distillated sterile/RNAse free water, pH: 6.1
Experiment:
SAXS data collected at EMBL P12, PETRA III
on 2019 Nov 10
Compact polyethylenimine-complexed mRNA molecules as quintessential vaccines
Martin
Schroer
R
g
Guinier
12.0
nm
D
max
40.0
nm
Volume
Porod
9100
nm
3
